IL6 and rheumatoid arthritis: Previous studies have suggested that IL-17 and TNF-α play a central role in RA, which results in reversion of MSC-induced immunosuppression, and the high levels of IL-6 in the presence of TNF-α may account for the lack of a beneficial effect of MSCs in CIA17, 42, 43.